Neither an intronic CA repeat within the CD48 gene nor the HERV-K18 polymorphisms are associated with type 1 diabetes

Tissue Antigens

Volumn 68, Issue 2, 2006, Pages 147-152

  Ramos Lopez, E ^a   Ghebru, S ^a   Van Autreve, J ^b   Aminkeng, F ^b   Herwig, J ^a   Seifried, E ^c   Seidl, C ^c   Van Der Auwera, B ^b   Badenhoop, K ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b FREE UNIVERSITY OF BRUSSELS   (Belgium)

^c Institute of Transfusion Medicine and Immunohaematology   (Germany)

Author keywords

CD48; HERV K18; Type 1 diabetes

Indexed keywords

CD48 ANTIGEN; SUPERANTIGEN; IDDMK1,2 22 SUPERANTIGEN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ARTICLE; BELGIUM; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GERMANY; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; RETROVIRUS; SCHOOL CHILD; CHILD; COMPUTER PROGRAM; DINUCLEOTIDE REPEAT; ENDOGENOUS RETROVIRUS; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; PRESCHOOL CHILD;

HUMAN ENDOGENOUS RETROVIRUS;

ANTIGENS, CD; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DINUCLEOTIDE REPEATS; ENDOGENOUS RETROVIRUSES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTRONS; LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC; SOFTWARE; SUPERANTIGENS;

EID: 33747201111     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2006.00637.x     Document Type: Article

References (24)

1. Mein CA, Esposito L, Dunn MG et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998: 19: 297-300.
2. Concannon P, Gogolin-Ewens KJ, Hinds DA et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998: 19: 292-6.
3. She JX. Susceptibility to type I diabetes. HLA-DQ DR revisited. Immunol Today 1996: 17: 323-9.
4. Steinman L. Escape from 'horror autotoxicus': pathogenesis and treatment of autoimmune disease. Cell 1995: 80: 7-10.
5. Hasuike S, Miura K, Miyoshi O et al. Isolation and localization of an IDDMK1,2-22-related human endogenous retroviral gene, and identification of a CA repeat marker at its locus. J Hum Genet 1999: 44: 343-7.
6. Tonjes RR, Czauderna F, Kurth R. Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol 1999: 73: 9187-95.
7. Conrad B, Weidmann E, Trucco G et al. Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology. Nature 1994: 371: 351-5.
8. Somoza N, Vargas F, Roura-Mir C et al. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 1994: 153: 1360-7.
9. Luppi P, Zanone MM, Hyoty H et al. Restricted TCR V beta gene expression and enterovirus infection in type I diabetes: a pilot study. Diabetologia 2000: 43: 1484-7.
10. Conrad B, Weissmahr RN, Boni J, Arcari R, Schupbach J, Mach B. A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 1997: 90: 303-13.
11. Marguerat S, Wang WY, Todd JA, Conrad B. Association of human endogenous retrovirus K-18 polymorphisms with type 1 diabetes. Diabetes 2004: 53: 852-4.
12. Meylan F, De Smedt M, Leclercq G et al. Negative thymocyte selection to HERV-K18 superantigens in humans. Blood 2005: 105: 4377-82.
13. Stauffer Y, Marguerat S, Meylan F et al. Interferon-alpha-induced endogenous superantigen. A model linking environment and autoimmunity. Immunity 2001: 15: 591-601.
14. Lapatschek M, Durr S, Lower R, Magin C, Wagner H, Miethke T. Functional analysis of the env open reading frame in human endogenous retrovirus IDDMK (1,2)22 encoding superantigen activity. J Virol 2000: 74: 6386-93.
15. Fisher RC, Thorley-Lawson DA. Characterization of the Epstein-Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48). Mol Cell Biol 1991: 11: 1614-23.
16. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955: 19: 251-3.
17. Donner H, Tonjes RR, Van der AB et al. The presence or absence of a retroviral long terminal repeat influences the genetic risk for type 1 diabetes conferred by human leukocyte antigen DQ haplotypes. Belgian Diabetes Registry. J Clin Endocrinol Metab 1999: 84: 1404-8.
18. Bieda K, Pani MA, van der AB et al. A retroviral long terminal repeat adjacent to the HLA DQB1 gene (DQ-LTR13) modifies Type I diabetes susceptibility on high risk DQ haplotypes. Diabetologia 2002: 45: 443-7.
19. Pani MA, Seidl C, Bieda K et al. Preliminary evidence that an endogenous retroviral long-terminal repeat (LTR13) at the HLA-DQB1 gene locus confers susceptibility to Addison's disease. Clin Endocrinol (Oxf) 2002: 56: 773-7.
20. Krach K, Badenhoop K, Tonjes RR. The IDDM-associated solitary retroviral promoters DQ-LTR3 and DQ-LTR13 have a distinct impact on the expression of selected DQB1 genes in different cell lines in vitro. Immunogenetics 2003: 55: 521-9.
21. Lower R, Tonjes RR, Boller K et al. Development of insulin-dependent diabetes mellitus does not depend on specific expression of the human endogenous retrovirus HERV-K. Cell 1998: 95: 11-4.
22. Azar GA, Thibodeau J. Human endogenous retrovirus IDDMK (1,2)22 and mouse mammary tumor virus superantigens differ in their ability to stimulate murine T cell hybridomas. Immunol Lett 2002; 81: 87-91.
23. Sutkowski N, Conrad B, Thorley-Lawson DA, Huber BT. Epstein-Barr virus transactivates the human endogenous retrovirus HERV-K18 that encodes a superantigen Immunity 2001: 15: 579-89.
24. Gonzalez-Cabrero J, Wise CJ, Latchman Y, Freeman GJ, Sharpe AH, Reiser H. CD48-deficient mice have a pronounced defect in CD4(+) T cell activation. Proc Natl Acad Sci USA 1999: 96: 1019-23.